Literature DB >> 12685559

Hyaluronan uptake by adult human skin fibroblasts in vitro.

M A Croce1, F Boraldi, D Quaglino, R Tiozzo, I Pasquali-Ronchetti.   

Abstract

Low and high molecular weight hyaluronan (HA) was added to adult human fibroblasts grown in monolayer to assess its influence on CD44 expression, its internalisation and effect on cell growth. CD44 expression on the surface of in vitro fibroblasts was not modified by different concentrations of FCS, whereas it was sensitive to cell cycle, being higher in the growing than in the resting phase. Independently from molecular weight, upon addition of exogenous HA (from 0.1 up to 1 mg/mL) to fibroblasts in the growing phase, a slight but constant decrease of the expression of CD44 on the surface of fibroblasts was observed; moreover, HA induced a rearrangement of CD44 into patches in close relationship with the terminal regions of stress fibers, which became thicker and more rigid after a few hours from the addition of HA to the medium. Fluorescent HA, added to the culture medium, rapidly attached to the plasma membrane and in less than two minutes was observed within cells, partly in association with its receptor CD44. By the contemporary use of neutral red, which accumulates into functional lysosomes, the great majority of internalised HA was found within lysosomes. HA receptor RHAMM-IHABP was rather homogeneously localised within the cytoplasm of normal growing fibroblasts. Upon addition of HA, the RHAMM-IHABP distribution became discontinuous around the nucleus. Addition of HA to fibroblasts induced a significant inhibition of cell growth, which was dependent on HA concentration and irrespective of HA molecular weight, at least in the ranges tested. Results show that extra-cellular HA is rapidly taken up by human dermal fibroblasts together with its CD44 receptor, and transported mostly to the lysosomes. Both low and high molecular weight HA induced down-regulation of cell proliferation, which would seem to be mediated by HA catabolism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12685559     DOI: 10.4081/808

Source DB:  PubMed          Journal:  Eur J Histochem        ISSN: 1121-760X            Impact factor:   3.188


  7 in total

1.  Inhibition of hyaluronan degradation by dextran sulphate facilitates characterisation of hyaluronan synthesis: an in vitro and in vivo study.

Authors:  Lishanthi Udabage; Gary R Brownlee; Robert Stern; Tracey J Brown
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

2.  ICAM-1 mediated peritoneal carcinomatosis, a target for therapeutic intervention.

Authors:  Nawar A Alkhamesi; Paul Ziprin; Katherine Pfistermuller; David H Peck; Ara W Darzi
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

3.  Regulation of valvular interstitial cell phenotype and function by hyaluronic acid in 2-D and 3-D culture environments.

Authors:  Karien J Rodriguez; Laura M Piechura; Kristyn S Masters
Journal:  Matrix Biol       Date:  2010-09-25       Impact factor: 11.583

4.  Role of Hyaluronic Acid Treatment in the Prevention of Keloid Scarring.

Authors:  Andrea Hoffmann; Jessica Lynn Hoing; Mackenzie Newman; Richard Simman
Journal:  J Am Coll Clin Wound Spec       Date:  2013-07-01

5.  Hyaluronan-CD44 interactions mediate contractility and migration in periodontal ligament cells.

Authors:  Zeinab Al-Rekabi; Adriane M Fura; Ilsa Juhlin; Alaa Yassin; Tracy E Popowics; Nathan J Sniadecki
Journal:  Cell Adh Migr       Date:  2019-02-08       Impact factor: 3.405

6.  Hyaluronan-Metal Gold Nanoparticle Hybrids for Targeted Tumor Cell Therapy.

Authors:  Vanessa Sanfilippo; Viviana Carmela Linda Caruso; Lorena Maria Cucci; Rosanna Inturri; Susanna Vaccaro; Cristina Satriano
Journal:  Int J Mol Sci       Date:  2020-04-27       Impact factor: 5.923

7.  A computational diffusion model to study antibody transport within reconstructed tumor microenvironments.

Authors:  Ana Luísa Cartaxo; Jaime Almeida; Emilio J Gualda; Maria Marsal; Pablo Loza-Alvarez; Catarina Brito; Inês A Isidro
Journal:  BMC Bioinformatics       Date:  2020-11-17       Impact factor: 3.169

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.